Emerging Infections in Dermatology

Seminars in Cutaneous Medicine and Surgery

Volumn 25, Issue 4, 2006, Pages 201-206

  Jackson, J Mark ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMMUNOGLOBULIN; METHOTREXATE; MINOCYCLINE; POLYSPORIN; PSEUDOMONIC ACID; RIFAMPICIN; RITUXIMAB; TETRACYCLINE;

ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; CARBUNCLE; CELLULITIS; CLINICAL FEATURE; DERMATOMYOSITIS; DIAGNOSTIC TEST; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FOLLICULITIS; HUMAN; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MEASLES LIKE RASH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; NONHUMAN; REVIEW; SKIN ABSCESS; SKIN INFECTION; SKIN ULCER; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; METHICILLIN RESISTANCE; MYCOBACTERIUM INFECTIONS, ATYPICAL; SKIN DISEASES; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33845428038     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2006.08.003     Document Type: Review

References (58)

1. Long S.S. Principles and Practice of Pediatric Infectious Diseases (1997), Churchill Livingstone, New York
2. Embil J., Ramotar K., Romance L., et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol 15 (1994) 646-651
3. Pan E.S., Binh A.D., Edwin D., et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus and their relation to community-associated disease activity. J Infect Dis 192 (2005) 811-818
4. LaMar J.E., Carr R.B., Zinderman C., et al. Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Mil Med 168 (2003) 135-138
5. Adcock P.M., Pator P., Medly F., et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 178 (1998) 577-580
6. Cohen P.R. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. Southern Med J 98 (2005) 596-602
7. Nguyen D.M., Mascola L., and Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11 (2005) 526-532
8. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
9. Begier E.M., Frenette K., Barrett N.L., et al. Connecticut Bioterrorism Field Epidemiology Response Team. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clini Infect Dis 39 (2004) 1446-1453
10. Lindenmayer J.M., Schoenfeld S., O'Grady R., et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 158 (1998) 895-899
11. Moreno F., Crisp F., Jorgenson J.H., et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 21 (1995) 1308-1312
12. Bukharie H.A., Abdelhadi M.S., Saeed I.A., et al. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 40 (2001) 1-4
13. Centers for Disease Control and Prevention: Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003 MMWR Morb Wkly Rep 52:88, 2003
14. Centers for Disease Control website. Available at: www.cdc.gov. Accessed August 23, 2006
15. Chambers H.F. The changing epidemiology of Staphylococcus aureus (review). Emerg Infect Dis 7 (2001) 178-182
16. Okuma K., Iwakawa K., Turnidge J.D., et al. Dissemination of new methicillin resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40 (2002) 4289-4294
17. Levison M.E., and Fung S. Community-associated methicillin-resistant Staphylococcus aureus: reconsideration of therapeutic options. Curr Infect Dis Rep 8 (2006) 23-30
18. Lee M.C., Rios A.M., Aten M.F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatric Infect Dis J 23 (2004) 123-127
19. Cohen P.R., and Grossman M.E. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 51 (2004) 132-135
20. Martinez-Aguilar G., Hammerman W.A., Mason Jr. E.O., et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 22 (2003) 593-598
21. Ruhe J.J., Monson T., Bradsher R.W., et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Curr Infect Dis 40 (2005) 1429-1434
22. Fung S., O'Grady S., Kennedy C., et al. The utility of polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study. Infection Control Hosp Epidemiol 21 (2000) 653-655
23. McCarthy J., and Hoagland R.J. Cutaneous manifestations of infectious mononucleosis. JAMA 187 (1964) 193-194
24. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 (2000) 481-492
25. Cliff S., Pettengell R., Gharge S., et al. B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. Br J Dermatol 140 (1999) 763-765
26. Kirby B., Owen C.M., Blewitt R.W., et al. Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy. J Am Acad Dermatol 47 suppl 2 (2002) S165-S167
27. Paul C., Le Tourneau A., Cayuela J.M., et al. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol 133 (1997) 903-904
28. Shapiro R., Nalesnik M., McCauley J., et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 68 (1999) 1851-1854
29. Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol JDD 5 (2006) 228-231
30. Iwatsuki K., Ohtsuka M., Harada H., et al. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 133 (1997) 1081-1086
31. Gilaberte M., Gallardo F., Bellosillo B., et al. Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma. Br J Dermatol 153 (2005) 828-832
32. Lucioni M., Ippoliti G., Campana C., et al. EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant 4 (2004) 1915-1920
33. Magro C.M., and Crowson A.N. Lichenoid and granulomatous dermatitis. Int J Dermatol 39 (2000) 126-133
34. Cho K.H., Lee S.H., Kim C.W., et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol 151 (2004) 372-380
35. Fardet L., Blanche S., Brousse N., et al. Cutaneous EBV-related lymphoproliferative disorder in a 15-year-old boy with AIDS: an unusual clinical presentation. J Pediatr Hematol Oncol 24 (2002) 666-669
36. Shirasaki F., Taniuchi K., Matsushita T., et al. Epstein-Barr virus-associated T-cell lymphoma: a case of eyelid swelling and intramuscular infiltration mimicking dermatomyositis. Br J Dermatol 1479 (2002) 1244-1248
37. Tan H.H., and Goh C.L. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol 7 (2006) 13-29
38. Capaldi L., Robinson-Bostom L., Kerr P., et al. Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder. J Am Acad Dermatol 51 (2004) 778-780
39. Drago F., Ranieri E., Pastorino A., et al. Epstein-Barr virus-related primary cutaneous amyloidosis. Successful treatment with acyclovir and interferon-alpha. Br J Dermatol 134 (1996) 170-174
40. Krause I., Wu R., Sherer Y., et al. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 12 (2002) 133-139
41. Green M., Reyes J., Webber S., et al. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 3 (2001) 97-103
42. Zompi S., Tulliez M., Conti F., et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. J Hepatol 32 (2000) 521-527
43. Sebire N.J., Haselden S., Malone M., et al. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 56 (2003) 555-557
44. Copur M.S., Deshpande A., Mleczko K., et al. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides. Croat Med J 46 (2005) 458-462
45. Haugmann G., and Lotti T. Atypical mycobacterial infections of the skin. Dermatol Clin 12 (1994) 657-668
46. Bartralot R., Garcia-Patos V., Sitjas D., et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol 152 (2005) 727-734
47. Runyon E.H. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 45 (1959) 273-290
48. Timpe A., and Runyon E.H. The relationship of "atypical" acid fast bacteria to human disease: a preliminary report. J Lab Clin Med 44 (1954) 202-209
49. Jernigan J.A., and Farr B.M. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Inf Dis 31 (2000) 439-443
50. Angeli K., Lacour J.P., Mantoux F., et al. Mycobacterium fortuitum skin infection occurring after a facelift. Ann Dermatol Venereol 131 (2004) 198-200
51. Jopp-McKay A.G., and Randell P. Sporotrichoid cutaneous infection due to Mycobacterium chelonei in a renal transplant patient. Aust J Dermatol 31 (1990) 105-109
52. Murdoch M.E., and Leigh I.M. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol 14 (1989) 309-312
53. Winthrop K.L., Albridge K., South D., et al. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis 38 (2004) 38-44
54. Murdoch M.E., Leigh I.M., Redbord K.P., et al. Atypical Mycobacterium furunculosis occurring after pedicures. J Am Acad Dermatol 54 (2006) 52-54
55. Sniezek P.J., Graham B.S., Busch H.B., et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 139 (2003) 629-634
56. Cummins D.L., Delacerda D., and Tausk F.A. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol 44 (2005) 518-520
57. Fujita N., Utani A., Matsumoto F., et al. Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection. J Am Acad Dermatol 29 (2002) 452-454
58. Nagore E., Ramos P., Botella-Estrada R., et al. Cutaneous infection with Mycobacterium fortuitum after localized microinjections treated successfully with a triple drug regimen. Acta Dermatol Venereol 81 (2001) 291-293